Q44481786 | Diagnosis of and therapy for hepatocellular carcinoma |
Q38210247 | Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. |
Q35584805 | Hepatocellular carcinoma in HIV-infected patients: check early, treat hard |
Q42228465 | Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. |
Q37831179 | Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. |
Q40583626 | Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis |
Q85120671 | Improved diagnosis of well‐differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid‐enhanced magnetic resonance imaging and Sonazoid contrast‐enhanced ultrasonography |
Q34125697 | Methodological issues for determining intervals of subsequent cancer screening |
Q51028212 | Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. |
Q28272678 | Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges |
Q36788468 | Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis |
Q83781767 | Small HCCs identified by screening |
Q47126334 | Sorafenib Improves Survival in Metastatic Hepatocellular Carcinoma: A Case Report |
Search more.